ANALYSIS: Australian device approvals could slide further with scrutiny hurdles
This article was originally published in SRA
The number of new medtech products on the Australian market has slowly declined over the six months to March 2013 and looks set to fall further if, as expected, tougher approval requirements are introduced for higher risk products.
You may also be interested in...
Nano-X Imaging is on a mission to disrupt the market for X-ray imaging equipment by offering a low-cost medical imaging service to untapped markets through a network of equipment dotted around the world. However, some shareholders are claiming the company mislead investors.
The test measures the relative level of antibodies, which could aid vaccine rollout.
The market for devices to treat chronic obstructive pulmonary disease (COPD) is set to grow by 5.0% annually in the next three years, with the US market expanding by 5.7% per year, according to the Meddevicetracker Dashboard.